These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27356459)

  • 1. Cardiac Resynchronization Therapy in Congestive Heart Failure Patients.
    Williams J
    Can J Cardiovasc Nurs; 2014; 24(3):3-5. PubMed ID: 27356459
    [No Abstract]   [Full Text] [Related]  

  • 2. [ Upgrading of cardiac resynchronization therapy devices in patients with heart failure--uprising clinical problem. ].
    Przybylski A
    Kardiol Pol; 2010 Nov; 68(11):1242. PubMed ID: 21108201
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A Review.
    Lappegård KT; Bjørnstad H; Mollnes TE; Hovland A
    Scand J Immunol; 2015 Sep; 82(3):191-8. PubMed ID: 26099323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [European Society of Cardiology guidelines on cardiac resynchronization therapy].
    Robinet S; Delcour A; Lancellotti P;
    Rev Med Liege; 2014 Apr; 69(4):180-7. PubMed ID: 24923097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac Resynchronization Therapy: How to Decrease Nonresponders.
    Tolosana JM; Mont L
    Heart Fail Clin; 2017 Jan; 13(1):233-240. PubMed ID: 27886928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in cardiac resynchronization therapy.
    Sankaranarayanan R; Visweswariah R; Fox DJ
    Br J Hosp Med (Lond); 2013 Sep; 74(9):503-9. PubMed ID: 24022551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy: the state of the art.
    Madias C; Trohman RG
    Expert Rev Cardiovasc Ther; 2014 May; 12(5):573-87. PubMed ID: 24749925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular endocardial leadless pacing brings new hope to patients with heart failure.
    Wang HX; Li XF; Zhang H; Sun S
    Int J Cardiol; 2013 Aug; 167(3):1073-4. PubMed ID: 23168008
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart rates in cardiac resynchronization: the art of optimal device programming.
    Maass AH; van Veldhuisen DJ
    Europace; 2011 Feb; 13(2):157-8. PubMed ID: 21186228
    [No Abstract]   [Full Text] [Related]  

  • 10. The transfemoral approach for cardiac resynchronization therapy.
    Chaggar PS; Skene C; Williams SG
    Europace; 2015 Feb; 17(2):173. PubMed ID: 25488956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing Readmissions With Novel Cardiac Resynchronization Therapy Programming: Is Meeting the 30-Day Metric Enough?
    Nohria A; Desai AS
    JACC Heart Fail; 2015 Jul; 3(7):573-575. PubMed ID: 26071615
    [No Abstract]   [Full Text] [Related]  

  • 12. Hybrid cardiac resynchronization with leadless pacemaker and transvenous coronary sinus lead.
    Kwok SY; Tse HF
    Europace; 2018 Sep; 20(9):1505. PubMed ID: 29868887
    [No Abstract]   [Full Text] [Related]  

  • 13. The emerging role of cardiac resynchronization therapy in milder heart failure: are we implanting too late for response?
    Bradfield J; Boyle NG; Mandapati R; Shivkumar K
    Curr Heart Fail Rep; 2012 Mar; 9(1):51-6. PubMed ID: 22135184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in a patient with a failing systemic right ventricle.
    Sugano A; Ishizu T; Nakamura A; Kawamatsu N; Kato Y; Takahashi M; Kanemoto S; Seo Y; Horigome H; Hiramatsu Y; Aonuma K
    Can J Cardiol; 2015 Jun; 31(6):819.e5-7. PubMed ID: 25922269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leadless endocardial left ventricular resynchronization: is it ready for prime time?
    Madhavan M; Friedman PA
    Europace; 2014 May; 16(5):623-5. PubMed ID: 24798955
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 17. Profile of St. Jude Medical's Allure Quadra quadripolar pacemaker system for cardiac resynchronization therapy.
    Corbisiero R; Muller D
    Expert Rev Med Devices; 2015 Jan; 12(1):41-8. PubMed ID: 25418543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New ESC heart failure guidelines with South African expert comment.
    Aalbers J
    Cardiovasc J Afr; 2012 Jun; 23(5):295-6. PubMed ID: 23077733
    [No Abstract]   [Full Text] [Related]  

  • 19. Resynchronization therapy in heart failure: the 'nonresponder'.
    Sinagra G; Proclemer A; Zecchin M
    J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e112-e115. PubMed ID: 29538157
    [No Abstract]   [Full Text] [Related]  

  • 20. The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume.
    Bogale N; Priori S; Gitt A; Alings M; Linde C; Dickstein K;
    Europace; 2011 Oct; 13(10):1445-53. PubMed ID: 21712274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.